SummaryCAP is the most common cause of community-acquired severe sepsis and S. pneumoniae is the most common pathogen to be identified in these patients. Early recognition of CAP is crucial to avoid delays in management. Although a combination of clinical scores and inflammatory biomarkers can stratify patients according to severity, currently their contribution to decisions about site and methods of treatment is poor. The availability of several scoring systems probably reflects a lack of a consensus